Jul 19, 2021
Welcome Ivy Lopez, Director of Patient Programs! It is with great excitement we announce that Ivy Lopez will join TMS in August as the Director of Patient Programs. In this new role, Ivy will be responsible for leading the overall programmatic delivery of education and learning for our community of patients, caregivers, and health care providers. […]
Apr 01, 2021
This week we lost a dear friend and advocate of the mast cell disease community, Rita Barlow. We are deeply saddened by this loss given her unwavering commitment to patients and TMS for many years. Rita served as TMS Chair from 2002-2009, Vice Chair 2009-2018 and as director emeritus after her retirement. Over the years, […]Feb 23, 2021
The Mast Cell Disease Society, Inc. (TMS) is excited to continue our partnership with the American Academy of Allergy, Asthma and Immunology (AAAAI) in offering the 2021 AAAAI/TMS Research Award in Mast Cell Disorders including Mastocytosis and/or Mast Cell Activation Syndrome. The RFP was released in 2020 and due in November 2020. This year’s award […]
Feb 17, 2021
The Mast Cell Disease Society, Inc. 2020 Needs Assessment Survey This survey was conducted from August 2020 – February 2021, and is now CLOSED. THANK YOU to those who shared their Mast Cell Disease-Related Needs and Concerns! The Mast Cell Disease Society, Inc. (TMS; DBA The Mastocytosis Society, Inc.) launched The TMS 2020 Mast Cell Disease […]
Jan 12, 2021
The Mast Cell Disease Society, Inc. (TMS) is proud to provide the following list of articles, book chapters, posters and invited presentations developed or contributed to by our TMS Research Committee and collaborators. The TouchStone SM Survey Working Group: Mesa RA, Sullivan EM, Dubinski D, Carroll B, Slee VM, Jennings S, Finnerty C, Bohannon […]
Oct 06, 2020
Below is a description of updates and progress on projects related to The Mast Cell Disease Society, Inc. (TMS) Research Committee. Major activities and initiatives are noted, but for a full list of activities in which the committee is involved, please see our Join the Research Committee section of this website. Where applicable, click on titles […]
Sep 12, 2020
It is with great excitement, that we announce the arrival of The Mast Cell Disease Society’s first-ever Executive Director – Lauren Denton. After completing a rigorous search process over the last three months we are thrilled for Lauren to begin her work with us on Monday, September 14th. Lauren joins with a decade of experience […]
Jun 17, 2020
The Mastocytosis Society, Inc. 2020 Patient Survey to Assess Impact of COVID-19 in Patients with Mast Cell Disease This survey will remain open for the foreseeable future You are invited to participate in a survey being conducted by Middle Tennessee State University (MTSU) researchers, in collaboration with The Mastocytosis Society, Inc. (TMS), designed to assess the […]
May 26, 2020
COVID-19 STATEMENT FROM THE MASTOCYTOSIS SOCIETY, INC. (TMS) AND PHYSICIANS FROM TMS MEDICIAL ADVISORY BOARD March 14, 2020 There have been many questions from patients affected by mast cell disease about the new coronavirus and if there are any precautions or changes in their medical management that should be undertaken. The Mastocytosis Society, Inc. (TMS) […]Apr 03, 2020
Good day, We hope you are all well and staying safe by practicing social distancing. For those who may not know, the FDA has withdrawn all prescription, generic and over the counter (OTC) Zantac® (ranitidine) from the market effective April 1, 2020. https://www.fda.gov/news-events/press-announcements/fda-requests-removal-all-ranitidine-products-zantac-market We recognize that this has deeply affected many members of our mast […]